LGND
Ligand Pharmaceuticals Incorporated

Market cap $3.1426B
Enterprise value $3.1619B
Employees 22
Revenue $129M
EBITDA $70.7M
Income $16.4M
EPS 0.78
P/E 190.65
Forward P/E 38.58
EV/EBITDA 44.75
PEG 1.76
Earnings date 2018-02-21
Volume 166k / 212k
Relative vol. 0.78 ×
Profit margin 12.76%
Oper. margin 46.66%
Gross margin 80.27%
Sales Q/Q -12.60%
Sales Y/Y 31.48%
Est. EPS Q/Q -11.20%
Beta 0.71
Mean Recomm. 2.20
IPO year 1994
Country United States
RSI 85.58
Range $147.68 – $149.24
52 weeks $95.08 – $149.31
SMA 50 $137 -8.16%
SMA 200 $133 -10.37%
1 year target $150 +0.96%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger